Health news
Risk assessment for lung cancer screening can be improved by combining a blood biomarker test and a risk prediction model, according to research published in the Journal of Clinical Oncology.1 Researchers found this method improved…
Neighborhood and individual socioeconomic disadvantage is associated with worse overall and cancer-specific survival among patients with nonmetastatic prostate, breast, lung, and colorectal cancer, according to study findings published online in JAMA Network Open. “Our findings…
A human leukocyte antigen (HLA) variant is associated with poor outcomes in patients with cancer who receive immune checkpoint inhibitors (ICIs), according to research published in The Lancet Oncology. The study showed that HLA-A*03 was…
Having an immune-mediated disease may increase a person’s risk of developing cancer, according to a large study published in JAMA Oncology. Researchers identified immune-mediated diseases associated with an elevated risk of cancer in the involved…
There is a lack of survival data for many oncology drugs approved for genomic indications in recent years, according to research published in the European Journal of Cancer. Researchers looked at drugs approved by the…
Studies have suggested that quality of life (QOL) assessments can predict progression-free survival (PFS) and overall survival (OS) in patients with cancer, though this doesn’t appear to hold true for all cancer types or in…
An international survey has revealed barriers to accessing cancer drugs deemed essential for routine clinical care. The survey was published in The Lancet Oncology. Researchers surveyed medical oncologists from 82 countries and found that some…
Lockdowns and restrictions due to the COVID-19 pandemic led to delays in cancer surgeries, but this did not seem to affect short-term outcomes for most patients, according to a study published in The Lancet Oncology.…
A study of more than 300,000 patients with COVID-19 and a history of cancer provides insights that can inform clinical care and etiologic studies, according to researchers. The group reported findings from this study in…
Although tracheal, bronchus, and lung cancer remained the leading cause of cancer-related mortality globally in 2019, the incidence of respiratory tract cancers and their mortality rates appear to have declined globally between 2010 and 2019—yet…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021